BioSpherix, LLC retweeted
How do we measure parameters for biofabricated tissues? What critical aspects of tissue engineered products remain unmonitored? Join us Dec 1st at NIST's virtual workshop to discuss measurement needs, future directions, and more.
nist.gov/news-events/events/…
BioSpherix, LLC retweeted
We are so thrilled to share this news!
phiab.com/pressrelease/phi-s…
#regenerativemedicine #biomanufacturing #celltherapies #holomonitor @BioSpherix @QIAGEN @WFIRMnews @SASsoftware
BioSpherix, LLC retweeted
Congratulations to Emma Warner, who finished her Summer Scholar project successfully in the Xvivo System at WFIRM with the help of the incredible Katie Benson! @WFIRMnews
#Cytocentric #CellCulture #RegenMed
BioSpherix, LLC retweeted
Watch our interview by @AliciaHenn of @BioSpherix on reproducibility of cell culture research and the importance of controlling cellular environment @KaustResearch @KAUST_SHI @Samhan182 @Dr_ShannonKlein youtu.be/n9HLuXedb2I
BioSpherix, LLC retweeted
⭐#IMPART PAPER SPOTLIGHT
Read it here: ncbi.nlm.nih.gov/pmc/article…
@BioSpherix
@simpsonlab_UofG @BruntLab @jade_marrow96 @prof_brunt @Jerm73
BioSpherix, LLC retweeted
Woah, that's an amazing video! 🎥
This Post is from an account that no longer exists. Learn more
BioSpherix, LLC retweeted
Glad to see our work in collaboration with the lab of @carlosduartephd on cell culture environment made to the #1 spot on the TOP 9 cytogenetic publications of 2021 @BioSpherix @KaustResearch @KAUST_News @Samhan182 @shaneparrish
The list is out! We picked our Top 9 Cytocentric Publications of 2021 biospherix.com/top-9-cytocen…
#cellculture #cytocentric
BioSpherix, LLC retweeted
Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin @utarlington #Anticancer #Hypoxia #Lightriggered #Ubertoxin #Ruthenium pubs.acs.org/doi/10.1021/jac…
BioSpherix, LLC retweeted
Thoroughly enjoyed another visit to see the inspiring researchers at @queensutime & @QueensuCPU and to celebrate a $1 million gift from the W.J. Henderson Foundation & the @QueensuDOM faculty physicians to support translational research.
BioSpherix, LLC retweeted
Cytocentric clinical research: Pierre-Yves Dumas et al. mimic the hematopoietic niche in vitro to demonstrate drug efficacy. Congratulations on your publication!
Read more: clincancerres.aacrjournals.o…
#ClinicalResearch #Cytocentric #Hematopoietic #AcuteMyeloidLeukemia #CellCulture
BioSpherix, LLC retweeted
Replying to @UAlbertaSurgery
@UAlbertaSurgery's @AlexSzojka et al. investigate a novel method for engineering meniscus: mechano-hypoxia conditioning. Congratulations on your publication!
Article (open acc): frontiersin.org/articles/10.…
#HypoxicConditioning #TissueEngineering #ExtracellularMatrix #Cytocentric
BioSpherix, LLC retweeted
We are the 1st research facility in the U.S. to use a custom-made barrier isolator for vaccine cell production #RPCICancerVaccine

















